famotidine has been researched along with metoclopramide in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Chan-Liao, DM; Liao, J | 1 |
| Braun, GG; Koppert, W; Martus, P; Mogendorf, F; Schmitt, H; Schywalsky, M; Voigt, HJ | 1 |
| Berstad, A; Hatlebakk, JG | 1 |
| Batra, YK; Kulkarni, PN; Wig, J | 1 |
| Cotten, CM; Gantz, M; Goldberg, RN; Goldstein, RF; Malcolm, WF; Martin, RJ | 1 |
| Trepanier, L | 1 |
| Kagawa, Y; Miyazaki, Y; Ohkawa, T; Sasakura, D; Uchino, T | 1 |
| Date, Y; Fujimura, Y; Inoue, H; Kihira, Y; Kojima, E; Kumagai, T; Narahara, N; Ogawa, S; Sato, E; Tsuruta, Y; Yoshitomi, H | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
3 review(s) available for famotidine and metoclopramide
| Article | Year |
|---|---|
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Cimetidine; Cisapride; Domperidone; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Metoclopramide; Nizatidine; Omeprazole; Pantoprazole; Piperidines; Proton Pump Inhibitors; Ranitidine; Sucralfate; Sulfoxides | 1996 |
Acute vomiting in cats: rational treatment selection.
Topics: Acute Disease; Animals; Antiemetics; Cat Diseases; Cats; Chlorpromazine; Diarrhea; Famotidine; Indoles; Metoclopramide; Nausea; Ondansetron; Prochlorperazine; Quinolizines; Quinuclidines; Ranitidine; Sucralfate; Vomiting; Weight Loss | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for famotidine and metoclopramide
| Article | Year |
|---|---|
Comparative study of famotidine and metoclopramide alone or combined for prophylaxis of aspiration pneumonitis.
Topics: Adult; Antiemetics; Clinical Trials as Topic; Drug Therapy, Combination; Famotidine; Humans; Metoclopramide; Middle Aged; Pneumonia, Aspiration; Preanesthetic Medication; Random Allocation; Thiazoles | 1988 |
[Drug induced prevention of the acid aspiration syndrome in non-elective cesarean section].
Topics: Cesarean Section; Citrates; Citric Acid; Famotidine; Female; Humans; Metoclopramide; Pneumonia, Aspiration; Pregnancy; Prospective Studies | 1994 |
Effects of different combinations of H2 receptor antagonist with gastrokinetic drugs on gastric fluid pH and volume in children--a comparative study.
Topics: Antiemetics; Child; Child, Preschool; Domperidone; Double-Blind Method; Drug Combinations; Famotidine; Gastric Juice; Gastrointestinal Contents; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Metoclopramide; Prospective Studies; Ranitidine; Receptors, Histamine H2 | 1997 |
12 other study(ies) available for famotidine and metoclopramide
| Article | Year |
|---|---|
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants.
Topics: Body Weight; Child Development; Cohort Studies; Continuity of Patient Care; Dose-Response Relationship, Drug; Drug Administration Schedule; Famotidine; Female; Follow-Up Studies; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Infant; Infant, Extremely Low Birth Weight; Infant, Newborn; Intensive Care Units, Neonatal; Male; Metoclopramide; Patient Discharge; Ranitidine; Retrospective Studies; Risk Assessment; Survival Rate; Time Factors; Treatment Outcome | 2008 |
Particle condition change in emulsion admixture evaluated by in situ flow particle imaging analysis.
Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Stability; Emulsions; Famotidine; Flurbiprofen; Hydrogen-Ion Concentration; Metoclopramide; Particle Size | 2013 |
[Stability of Six Drugs in Total Parenteral Nutrition Solution].
Topics: Betamethasone; Bromhexine; Butylscopolammonium Bromide; Drug Packaging; Drug Stability; Famotidine; Furosemide; Metoclopramide; Parenteral Nutrition Solutions; Parenteral Nutrition, Home Total | 2021 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |